MA52348A - Composés hétéroaromatiques ayant une activité contre vrs - Google Patents

Composés hétéroaromatiques ayant une activité contre vrs

Info

Publication number
MA52348A
MA52348A MA052348A MA52348A MA52348A MA 52348 A MA52348 A MA 52348A MA 052348 A MA052348 A MA 052348A MA 52348 A MA52348 A MA 52348A MA 52348 A MA52348 A MA 52348A
Authority
MA
Morocco
Prior art keywords
activity against
heteroaromatic compounds
against rsv
rsv
heteroaromatic
Prior art date
Application number
MA052348A
Other languages
English (en)
Inventor
Sovy Chao
Jérôme Émile Georges Guillemont
David Francis Alain Lançois
Antoine Benjamin Michaut
Sabrina Dany France Quatrevaux
Pierre Jean-Marie Bernard Raboisson
Peter Rigaux
Dirk André Emmy Roymans
Original Assignee
Janssen Sciences Ireland Unlimited Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Unlimited Co filed Critical Janssen Sciences Ireland Unlimited Co
Publication of MA52348A publication Critical patent/MA52348A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
MA052348A 2018-04-23 2019-04-19 Composés hétéroaromatiques ayant une activité contre vrs MA52348A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18168671 2018-04-23

Publications (1)

Publication Number Publication Date
MA52348A true MA52348A (fr) 2021-03-03

Family

ID=62046706

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052348A MA52348A (fr) 2018-04-23 2019-04-19 Composés hétéroaromatiques ayant une activité contre vrs

Country Status (13)

Country Link
US (1) US11708369B2 (fr)
EP (1) EP3784667B1 (fr)
JP (1) JP2021522222A (fr)
KR (1) KR20210005569A (fr)
CN (1) CN112004815A (fr)
AU (1) AU2019260109B2 (fr)
CA (1) CA3095277A1 (fr)
EA (1) EA202092439A1 (fr)
ES (1) ES2957316T3 (fr)
MA (1) MA52348A (fr)
MX (1) MX2020011200A (fr)
SG (1) SG11202010323QA (fr)
WO (1) WO2019206828A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3087926A1 (fr) 2018-01-31 2019-08-08 Janssen Sciences Ireland Unlimited Company Pyrazolopyrimidines substituees par cycloalkyle ayant une activite contre le vrs
KR20210005569A (ko) * 2018-04-23 2021-01-14 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 Rsv에 대한 활성을 갖는 헤테로방향족 화합물
EP4171547A1 (fr) 2020-05-27 2023-05-03 Axial Therapeutics, Inc. Composés modulateurs de tlr2, compositions pharmaceutiques et leurs utilisations

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4250596A (en) 1994-12-22 1996-07-10 Biochem Pharma Inc. Low molecular weight bicyclic thrombin inhibitors
WO1997001275A1 (fr) 1995-06-29 1997-01-16 Merck & Co., Inc. Combinaisons d'inhibiteurs de farnesyl-proteine transferase
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
US5972966A (en) 1996-12-05 1999-10-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5977134A (en) 1996-12-05 1999-11-02 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6177443B1 (en) 1997-03-07 2001-01-23 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and use
CA2375909A1 (fr) 1999-07-19 2001-01-25 Shionogi & Co., Ltd. Composes tricycliques porteurs de pendants acyloxymethoxycarbonyle
EP1113007A1 (fr) 1999-12-24 2001-07-04 Pfizer Inc. Composés de tétrahydroisoquinoline comme agonistes/antagonistes d'oestrogène
WO2003016274A2 (fr) 2001-08-21 2003-02-27 Sepracor, Inc. Piperidines 2-substitue, ligands pour des recepteurs et des transporteurs de monoamines
CA2483306A1 (fr) 2002-04-23 2003-11-06 Shionogi & Co., Ltd. Derive de pyrazolo[1,5-a]pyrimidine et inhibiteur de la nad(p)h oxydase contenant ledit derive
CA2499523C (fr) 2002-09-20 2011-04-19 Medisyn Technologies, Inc. Agents therapeutiques et traitements correspondants
EP1546132A1 (fr) 2002-09-26 2005-06-29 Pfizer Limited Derives de pyrazole utilises en tant qu'inhibiteurs de la transcriptase inverse
WO2004037817A1 (fr) 2002-10-25 2004-05-06 Mitsubishi Pharma Corporation Composes de n-oxyde
AR043633A1 (es) 2003-03-20 2005-08-03 Schering Corp Ligandos de receptores de canabinoides
EP2258365B1 (fr) 2003-03-28 2013-05-29 Novartis Vaccines and Diagnostics, Inc. Utilisation de composés organiques pour potentialiser l'immunité
FR2856596B1 (fr) 2003-06-27 2007-04-27 Bioprojet Soc Civ Nouvelle association medicamenteuse psychiatrique et utilisation d'une antagoniste ou agoniste inverse du recepteur h3 de l'histamine pour preparer un medicament prevenant des effets indesirables de psychotropes.
EP1671962A1 (fr) 2003-10-10 2006-06-21 Ono Pharmaceutical Co., Ltd. Nouveau compose heterocyclique fondu et utilisation correspondante
CA2541618C (fr) 2003-10-30 2011-12-13 Boehringer Ingelheim (Canada) Ltd. Inhibiteurs polymerase rsv
AR046959A1 (es) 2003-12-18 2006-01-04 Tibotec Pharm Ltd Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio
KR20060127909A (ko) 2003-12-24 2006-12-13 비오타 사이언티픽 매니지먼트 피티와이 엘티디 호흡기 다핵체 바이러스 감염 치료용 다환 물질
CN101775013A (zh) 2004-09-13 2010-07-14 小野药品工业株式会社 含氮杂环衍生物及含有其作为活性成分的药物
EP2316458A1 (fr) 2004-09-20 2011-05-04 Xenon Pharmaceuticals Inc. Derives de pyridazine destines a l'inhibition du desaturase-coa-stearoyl de l'humain
WO2007044085A2 (fr) 2005-05-19 2007-04-19 Xenon Pharmaceuticals Inc. Composes heteroaryle et leurs utilisations en tant qu'agents therapeutiques
CA2612263C (fr) 2005-06-20 2015-04-14 Tibotec Pharmaceuticals Ltd. 1-(2-amino-3-(alkyl substitue)-3h-benzimidazolylmethyl)-(3-subtitue)-1,3-dihydrobenzoimidazol-2-ones ayant une activite sur le virus syncyntial respiratoire
US7507842B2 (en) 2005-08-12 2009-03-24 Radiorx, Inc. Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
US20090111828A1 (en) 2005-11-23 2009-04-30 Astrazeneca Ab L-alanine derivatives
US20080176870A1 (en) 2006-11-20 2008-07-24 Bert Nolte Heterobicyclic metalloprotease inhibitors
AU2008287421A1 (en) 2007-08-10 2009-02-19 Glaxosmithkline Llc Nitrogen containing bicyclic chemical entities for treating viral infections
KR20100094554A (ko) 2007-12-06 2010-08-26 쉐링 코포레이션 감마 세크레타제 조절인자
US20100063047A1 (en) 2008-09-10 2010-03-11 Kalypsys, Inc. Aminopyrimidine inhibitors of histamine receptors for the treatment of disease
CA2738453C (fr) 2008-10-23 2017-07-04 Boehringer Ingelheim International Gmbh Derivees d'uree de nortropanes substitues, medicaments contenant de tels composes et leur utilisation
US20100204265A1 (en) 2009-02-09 2010-08-12 Genelabs Technologies, Inc. Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
WO2010104307A2 (fr) 2009-03-07 2010-09-16 주식회사 메디젠텍 Compositions pharmaceutiques pour traiter ou prévenir des maladies causées par la translocation de gsk3 du noyau cellulaire au cytoplasme, contenant des composés inhibant la translocation de gsk3 du noyau cellulaire au cytoplasme
US9238647B2 (en) 2009-03-23 2016-01-19 Merck Sharp & Dohme Corp. P2X3 receptor antagonists for treatment of pain
JP5530514B2 (ja) 2009-06-11 2014-06-25 アッヴィ・バハマズ・リミテッド Ｈｃｖ感染を治療するための抗ウィルス化合物
US8937150B2 (en) 2009-06-11 2015-01-20 Abbvie Inc. Anti-viral compounds
EA201591390A1 (ru) * 2010-06-24 2016-06-30 Джилид Сайэнс, Инк. Пиразол[1,5-a]пиримидины для противовирусного лечения
EP2794611B1 (fr) 2011-12-22 2017-10-11 Gilead Sciences, Inc. Pyrazolo[1,5]pyrimidines en tant qu'agents antiviraux
CN106986869A (zh) * 2012-04-17 2017-07-28 吉利德科学公司 用于抗病毒治疗的化合物和方法
JP6564380B2 (ja) 2013-09-20 2019-08-21 ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 前立腺癌を治療するための化合物
JP6510539B2 (ja) 2014-01-09 2019-05-08 ザ ジェイ． デヴィッド グラッドストーン インスティテューツ， ア テスタメンタリー トラスト エスタブリッシュド アンダー ザ ウィル オブ ジェイ． デヴィッド グラッドストーン 置換ベンゾオキサジン及び関連化合物
KR101551313B1 (ko) 2014-07-28 2015-09-09 충남대학교산학협력단 신규한 인덴 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 망막 질환의 예방 또는 치료용 약학적 조성물
WO2016071293A2 (fr) 2014-11-03 2016-05-12 Iomet Pharma Ltd Composé pharmaceutique
EA032081B1 (ru) 2014-12-08 2019-04-30 Янссен Сайенсиз Айрлэнд Юси ЗАМЕЩЕННЫЕ ПИПЕРИДИНОМ ПРОИЗВОДНЫЕ ПИРАЗОЛО[1,5-a]ПИРИМИДИНА С ИНГИБИРУЮЩЕЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ РЕПЛИКАЦИИ РЕСПИРАТОРНО-СИНЦИТИАЛЬНОГО ВИРУСА (RSV)
CN105777632A (zh) 2015-01-09 2016-07-20 成都贝斯凯瑞生物科技有限公司 芳环并氮杂环衍生物及其应用
JO3637B1 (ar) 2015-04-28 2020-08-27 Janssen Sciences Ireland Uc مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv
TW201932470A (zh) 2017-11-29 2019-08-16 愛爾蘭商健生科學愛爾蘭無限公司 具有抗ｒｓｖ活性之吡唑并嘧啶
CA3087926A1 (fr) 2018-01-31 2019-08-08 Janssen Sciences Ireland Unlimited Company Pyrazolopyrimidines substituees par cycloalkyle ayant une activite contre le vrs
KR20210005569A (ko) 2018-04-23 2021-01-14 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 Rsv에 대한 활성을 갖는 헤테로방향족 화합물
JP2022507779A (ja) 2018-11-26 2022-01-18 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー Ｒｓｖに対する活性を有するさらなるヘテロ芳香族化合物
WO2020234333A1 (fr) 2019-05-23 2020-11-26 Janssen Sciences Ireland Unlimited Company Autres composés hétéroaromatiques ayant une activité contre le vrs

Also Published As

Publication number Publication date
ES2957316T3 (es) 2024-01-17
AU2019260109B2 (en) 2023-07-13
EP3784667A1 (fr) 2021-03-03
MX2020011200A (es) 2020-11-13
EP3784667B1 (fr) 2023-08-16
CA3095277A1 (fr) 2019-10-31
US20210094958A1 (en) 2021-04-01
EA202092439A1 (ru) 2021-03-05
WO2019206828A1 (fr) 2019-10-31
CN112004815A (zh) 2020-11-27
AU2019260109A1 (en) 2020-09-17
KR20210005569A (ko) 2021-01-14
SG11202010323QA (en) 2020-11-27
US11708369B2 (en) 2023-07-25
EP3784667C0 (fr) 2023-08-16
JP2021522222A (ja) 2021-08-30

Similar Documents

Publication Publication Date Title
MA54859A (fr) Composés 3-carbonylamino-5-cyclopentyl-1h-pyrazole ayant une activité inhibitrice de cdk2
MA47131A (fr) Composés benzyl-amide phosphodiamide antiviraux
MA49900A (fr) Composés herbicides
MA52948A (fr) Composés
MA41614A (fr) Composés antiviraux
MA51669A (fr) Composés
MA45940A (fr) Composé hétérocyclique
MA53003A (fr) Composés
DK3418275T3 (da) Hidtil ukendt 2,3,5-substitueret thiophenforbindelse som proteinkinasehæmmer
MA52348A (fr) Composés hétéroaromatiques ayant une activité contre vrs
BR112017023150A2 (pt) compostos herbicidas.
MA44020A (fr) Composés antitumoraux
DK3638680T3 (da) Heteroaromatiske forbindelser som vanininhibitorer
MA53547A (fr) Composés de 2,6-diamino pyridine
MA49621A (fr) Composés bifonctionnels
MA50504A (fr) Composés antibactériens
DK3844161T3 (da) Heteroaromatiske forbindelser som vanininhibitorer.
IT201700038155U1 (it) Trasportino per animali domestici
MA52946A (fr) Composés
MA54286A (fr) Autres composés hétéroaromatiques ayant une activité contre le vrs
MA51221A (fr) Composés de pyrazolopyridinone
CL2019000361S1 (es) Escobilla.
DK3891142T3 (da) Heteroaromatiske forbindelser som vanininhibitorer
MA52297A (fr) Composé hétérocyclique
MA51197A (fr) Pyrazolopyrimidines ayant une activité contre le virus respiratoire syncytial (vrs)